Substantial population protection from Invasive Pneumococcal Disease associated with PCV10 vaccine program in Kilifi, Kenya

Research Brief, April 2019





The Pneumococcal Conjugate Vaccine Impact Study (PCVIS) has demonstrated the population effects of 10-valent Pneumococcal Conjugate Vaccine (PCV10) in Kenya. This brief focuses on the substantial impact of PCV10 on invasive pneumococcal disease (IPD) and pneumococcal carriage and highlights areas for further research.